These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4427254)

  • 81. In vitro-in vivo extrapolation method to predict human renal clearance of drugs.
    Kunze A; Huwyler J; Poller B; Gutmann H; Camenisch G
    J Pharm Sci; 2014 Mar; 103(3):994-1001. PubMed ID: 24549735
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Monitoring pediatric iv drugs.
    Smith SC; Crass RE
    Drug Intell Clin Pharm; 1984 Jun; 18(6):530-1. PubMed ID: 6734441
    [No Abstract]   [Full Text] [Related]  

  • 83. Drug bioavailability information and its utility.
    Chun AH; Seitz JA
    J Am Pharm Assoc; 1974 Aug; 14(8):407-14. PubMed ID: 4851441
    [No Abstract]   [Full Text] [Related]  

  • 84. Use of confidence intervals in analysis of comparative bioavailability trials.
    Westlake WJ
    J Pharm Sci; 1972 Aug; 61(8):1340-1. PubMed ID: 5050398
    [No Abstract]   [Full Text] [Related]  

  • 85. Influence of urinary pH on the pharmacokinetics of cinoxacin in humans and on antibacterial activity in vitro.
    Barbhaiya RH; Gerber AU; Craig WA; Welling PG
    Antimicrob Agents Chemother; 1982 Mar; 21(3):472-80. PubMed ID: 7103450
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Measurement of the renal clearance of drugs.
    Tucker GT
    Br J Clin Pharmacol; 1981 Dec; 12(6):761-70. PubMed ID: 7041933
    [No Abstract]   [Full Text] [Related]  

  • 87. Absolute drug bioavailability II: Evaluation of renal clearance perturbation method using literature data assuring a fraction absorbed of unity.
    Lalka D; du Souich P; McLean AJ; Gibaldi M
    J Pharm Sci; 1978 Apr; 67(4):591-2. PubMed ID: 641784
    [No Abstract]   [Full Text] [Related]  

  • 88. Novel method for bioavailability assessment.
    Kwan KC; Till AE
    J Pharm Sci; 1973 Sep; 62(9):1494-7. PubMed ID: 4743100
    [No Abstract]   [Full Text] [Related]  

  • 89. Individualized estimation of clearance following a loading dose and continuous intravenous infusion using a programmable calculator.
    Mitsuoka JC; Fleck RJ
    Comput Programs Biomed; 1983; 16(1-2):21-5. PubMed ID: 6687852
    [No Abstract]   [Full Text] [Related]  

  • 90. The significance of the arterial-venous plasma concentration difference in clearance studies.
    Chiou WL; Lam G
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):197-203. PubMed ID: 7095918
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Letter: Absolute drug bioavailability: approximation without comparison to parenteral dose for compounds exhibiting perturbable renal clearance.
    Lalka D; Feldman H
    J Pharm Sci; 1974 Nov; 63(11):1812. PubMed ID: 4427254
    [No Abstract]   [Full Text] [Related]  

  • 92. Bioavailability of drugs (first of two parts).
    Koch-Weser J
    N Engl J Med; 1974 Aug; 291(5):233-7. PubMed ID: 4600408
    [No Abstract]   [Full Text] [Related]  

  • 93. Bioavailability of drugs (second of two parts).
    Koch-Weser J
    N Engl J Med; 1974 Sep; 291(10):503-6. PubMed ID: 4604153
    [No Abstract]   [Full Text] [Related]  

  • 94. Bioavailability and pharmacokinetic analysis of drug responding systems.
    Smolen VF
    Annu Rev Pharmacol Toxicol; 1978; 18():495-522. PubMed ID: 348066
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.